EudraCT Number: 2020-000228-20 Sponsor Protocol Number: 16012020001 Start Date: 2020-08-28
Sponsor Name: Medical University of Graz
Full Title: Probiotic dietary Intervention in Polycystic Ovary Syndrome – A Randomized Controlled Trial
Medical condition: Polycystic Ovary Syndrome (PCOS) is a hormonal and metabolic disorder affecting up to 20 percent of women worldwide, depending on diagnostic criteria. A very common definition of PCOS based on the ...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: AT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2020-000160-28 Sponsor Protocol Number: MusicPlasticity Start Date: 2020-08-28
Sponsor Name: Medical University of Vienna
Full Title: Investigation of SSRI induced neuroplastic changes in musicians using functional magnetic resonance imaging
Medical condition: Focal dystonia in musicians
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: AT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2020-000195-38 Sponsor Protocol Number: D3252C00004 Start Date: 2020-08-17
Sponsor Name: AstraZeneca AB
Full Title: A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Benralizumab for the Prevention of Recurrence of Nasal Polyps Following Surgical Rem...
Medical condition: Nasal polyposis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Ongoing)
Trial results: (No results available)

EudraCT Number: 2020-000348-77 Sponsor Protocol Number: XL184-315 Start Date: 2020-07-22
Sponsor Name: Exelixis, Inc.
Full Title: A Phase 3, Randomized, Open-Label, Controlled Study of Cabozantinib (XL184) in Combination with Atezolizumab vs Second Novel Hormonal Therapy (NHT) in Subjects with Metastatic Castration-Resistant ...
Medical condition: Metastatic Castration-Resistant Prostate Cancer
Disease: Version SOC Term Classification Code Term Level
21.1 100000004864 10076506 Castration-resistant prostate cancer LLT
Population Age: Adults, Elderly Gender: Male
Trial protocol: HU (Ongoing) GB (Ongoing)
Trial results: (No results available)
EudraCT Number: 2019-003107-35 Sponsor Protocol Number: ARGX-113-1902 Start Date: 2020-07-15
Sponsor Name: argenx BVBA
Full Title: Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuro...
Medical condition: Chronic Inflammatory Demyelinating Polyneuropathy
Disease: Version SOC Term Classification Code Term Level
20.0 100000004852 10077384 Chronic inflammatory demyelinating polyneuropathy LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Ongoing) BE (Ongoing) HU (Ongoing) PL (Ongoing) GB (Ongoing)
Trial results: (No results available)

EudraCT Number: 2017-000693-11 Sponsor Protocol Number: MK-8616-169 Start Date: 2019-08-05
Sponsor Name: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Full Title: A Phase 4 Double-blinded, Randomized, Active Comparator-controlled Clinical Trial to Study the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade ...
Medical condition: Neuromuscular Blockade reversal
Disease: Version SOC Term Classification Code Term Level
21.1 10042613 - Surgical and medical procedures 10057286 Neuromuscular blockade reversal PT
Population Age: Newborns, Infants and toddlers, Under 18 Gender: Male, Female
Trial protocol: BE (Ongoing) DK (Ongoing) FI (Ongoing) HU (Ongoing) NL (Ongoing) FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2019-000134-18 Sponsor Protocol Number: RenoMet Start Date: 2019-08-26
Sponsor Name: University of Antwerp
Full Title: Metformin as RenoProtector in Non-Diabetic Patients with Progressive Chronic Kidney Disease (CKD stages 2, 3A and 3B): a multi-centre, practice-oriented, repurposing, double-blind, placebo-contro...
Medical condition: Chronic Kidney Disease (CKD stage 2, 3A, 3B)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: BE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2018-004774-97 Sponsor Protocol Number: C-935788-057 Start Date: 2019-10-23
Sponsor Name: Rigel Pharmaceuticals, Inc.
Full Title: A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Medical condition: Warm antibody autoimmune hemolytic anemia (wAIHA)
Disease: Version SOC Term Classification Code Term Level
20.0 100000004851 10003825 Autoimmune hemolytic anemia LLT
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Ongoing) BG (Ongoing) ES (Ongoing) CZ (Ongoing) HU (Ongoing) DK (Ongoing) DE (Restarted) AT (Ongoing) BE (Ongoing) NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2015-005455-28 Sponsor Protocol Number: WN40226 Start Date: 2020-09-28
Sponsor Name: F. Hoffmann-La Roche Ltd
Full Title: A Multi-Site, Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Subcutaneous Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7239361 (BMS-986089) in Ambula...
Medical condition: Duchenne Muscular Dystrophy
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10013801 Duchenne muscular dystrophy PT
Population Age: Children, Under 18 Gender: Male
Trial protocol: Outside EU/EEA
Trial results: (No results available)

EudraCT Number: 2019-000883-40 Sponsor Protocol Number: TP0004 Start Date: 2020-09-29
Sponsor Name: UCB Biopharma SRL
Full Title: An Open-Label Extension Study to Investigate the Long-Term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
Medical condition: Primary Immune Thrombocytopenia
Disease: Version SOC Term Classification Code Term Level
20.0 10005329 - Blood and lymphatic system disorders 10043554 Thrombocytopenia PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Ongoing)
Trial results: (No results available)